TY - JOUR
T1 - A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus
AU - Broxmeyer, Hal E.
AU - Dent, Alexander
AU - Cooper, Scott
AU - Hangoc, Giao
AU - Wang, Zheng Yu
AU - Du, Wenjun
AU - Gervay-Haque, Jacquelyn
AU - Sriram, Venkataraman
AU - Renukaradhya, Gourapura J.
AU - Brutkiewicz, Randy R.
N1 - Funding Information:
These studies were supported by U.S. Public Health Service Grants RO1 HL56416 and RO1 HL67384 from the NIH to HEB and RO1 AI46455 and PO1 AI056097 to RRB.
PY - 2007/4
Y1 - 2007/4
N2 - Objective: Infection of immunocompromised patients with cytomegalovirus (CMV), such as that occurring in patients undergoing hematopoietic stem cell transplantation, is a serious clinical problem. CMV infection has been reported to suppress hematopoiesis. In immunocompetent hosts CMV is controlled initially by the innate immune system, with CD1d molecules and natural killer T (NKT) cells playing a role in the antiviral immune response in several model systems. We hypothesized that CD1d and NKT cells are involved in protection of the hematopoietic modulating effects of CMV, and that adoptive transfer of NKT cells would protect against these infection-induced effects. Methods: To address our hypothesis, we used a murine CMV (MCMV) infection model in CD1d-/-, Jα18-/-, and wild-type (WT) control mice of two different genetic strains each. Results: Infection with MCMV was associated with significant suppression of absolute numbers and cell cycling status of myeloid progenitor cells (CFU-GM, BFU-E, CFU-GEMM) in the marrow and spleen, especially in CD1d-/- (lack both CD1d and NKT cells), and Jα18-/- (express CD1d but lack NKT cells) mice. Adoptive transfer of NKT cells into WT and Jα18-/- mice shortly before infection with MCMV counteracted myelosuppression. Conclusions: The results implicate NKT cells, and also likely CD1d, in protection of progenitor cells from MCMV-induced suppression and suggest that NKT cells may be of value in an adoptive transfer setting to treat CMV-induced perturbations of hematopoiesis in immunocompromised individuals. However, further studies are required to better understand the full consequences of adoptive transfer in these settings.
AB - Objective: Infection of immunocompromised patients with cytomegalovirus (CMV), such as that occurring in patients undergoing hematopoietic stem cell transplantation, is a serious clinical problem. CMV infection has been reported to suppress hematopoiesis. In immunocompetent hosts CMV is controlled initially by the innate immune system, with CD1d molecules and natural killer T (NKT) cells playing a role in the antiviral immune response in several model systems. We hypothesized that CD1d and NKT cells are involved in protection of the hematopoietic modulating effects of CMV, and that adoptive transfer of NKT cells would protect against these infection-induced effects. Methods: To address our hypothesis, we used a murine CMV (MCMV) infection model in CD1d-/-, Jα18-/-, and wild-type (WT) control mice of two different genetic strains each. Results: Infection with MCMV was associated with significant suppression of absolute numbers and cell cycling status of myeloid progenitor cells (CFU-GM, BFU-E, CFU-GEMM) in the marrow and spleen, especially in CD1d-/- (lack both CD1d and NKT cells), and Jα18-/- (express CD1d but lack NKT cells) mice. Adoptive transfer of NKT cells into WT and Jα18-/- mice shortly before infection with MCMV counteracted myelosuppression. Conclusions: The results implicate NKT cells, and also likely CD1d, in protection of progenitor cells from MCMV-induced suppression and suggest that NKT cells may be of value in an adoptive transfer setting to treat CMV-induced perturbations of hematopoiesis in immunocompromised individuals. However, further studies are required to better understand the full consequences of adoptive transfer in these settings.
UR - http://www.scopus.com/inward/record.url?scp=33947279009&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2007.01.015
DO - 10.1016/j.exphem.2007.01.015
M3 - Article
C2 - 17379092
AN - SCOPUS:33947279009
SN - 0301-472X
VL - 35
SP - 87
EP - 93
JO - Experimental Hematology
JF - Experimental Hematology
IS - 4 SUPPL.
ER -